2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$117.15+$0.04 (+0.03%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.3BMarket Cap
- 128.11%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$117.15+$0.04 (+0.03%)
HAE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $117.11 | ||
Change | -$1.10 (-0.93%) | ||
Open | $117.49 | ||
High | $119.14 | ||
Low | $116.65 | ||
Previous Close | $118.21 | ||
Volume | 843,472 | ||
30-Day Average Volume | 687,998 | ||
1-Week Change | -3.30% | ||
1-Month Change | 7.71% | ||
1-Year Change | 128.11% | ||
3-Year Change | 31.51% | ||
5-Year Change | 63.49% | ||
Fundamentals | |||
Shares Outstanding | 45.5M | ||
Total Assets | $2.4B | ||
Market Cap | $5.3B | ||
Enterprise Value | $6.3B | ||
Period: QTR TTM FY | |||
Revenue | $339.4M | ||
Net Income | $33.0M | ||
Free Cash Flow | $44.4M | ||
EBIT | $52.8M | ||
EBITDA | $79.9M | ||
Net Working Capital | $547.6M | ||
EPS | $0.72 | ||
Enterprise Value/EBITDA | 79 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 6 | ||
P/E | 163 | ||
PEG | 1 | ||
Price/Free Cash Flow | 120 | ||
Price/Operating Cash Flow | 102 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 12/03/2012 | ||
Earnings & Revenue